Cambridge Investment Research Advisors’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-432
| Closed | -$8K | – | 3212 |
|
2022
Q1 | $8K | Buy |
432
+92
| +27% | +$1.7K | ﹤0.01% | 3149 |
|
2021
Q4 | $6K | Buy |
340
+32
| +10% | +$565 | ﹤0.01% | 3159 |
|
2021
Q3 | $11K | Hold |
308
| – | – | ﹤0.01% | 3072 |
|
2021
Q2 | $18K | Buy |
308
+21
| +7% | +$1.23K | ﹤0.01% | 3067 |
|
2021
Q1 | $19K | Sell |
287
-25
| -8% | -$1.66K | ﹤0.01% | 2846 |
|
2020
Q4 | $19K | Buy |
312
+16
| +5% | +$974 | ﹤0.01% | 2687 |
|
2020
Q3 | $23K | Sell |
296
-229
| -44% | -$17.8K | ﹤0.01% | 2485 |
|
2020
Q2 | $33K | Sell |
525
-20
| -4% | -$1.26K | ﹤0.01% | 2398 |
|
2020
Q1 | $29K | Sell |
545
-56
| -9% | -$2.98K | ﹤0.01% | 2219 |
|
2019
Q4 | $73K | Sell |
601
-78
| -11% | -$9.47K | ﹤0.01% | 2337 |
|
2019
Q3 | $123K | Buy |
679
+180
| +36% | +$32.6K | ﹤0.01% | 2212 |
|
2019
Q2 | $65K | Buy |
499
+156
| +45% | +$20.3K | ﹤0.01% | 2132 |
|
2019
Q1 | $84K | Buy |
+343
| New | +$84K | ﹤0.01% | 2199 |
|
2017
Q2 | – | Sell |
-249
| Closed | -$90K | – | 1984 |
|
2017
Q1 | $90K | Buy |
249
+14
| +6% | +$5.06K | ﹤0.01% | 1705 |
|
2016
Q4 | $68K | Buy |
+235
| New | +$68K | ﹤0.01% | 1611 |
|